Key result
Women with polycystic ovary syndrome had significantly lower serum adiponectin levels compared to healthy controls (7.59 vs 10.19 μg/dL, p=0.001).
Why the study?
Are serum adiponectin levels decreased in Indian women under 30 with PCOS compared to healthy controls?
Case-Control (n=90)
No
Are serum adiponectin levels decreased in Indian women under 30 with PCOS compared to healthy controls?
Absolute Event Rate: 7.59% vs 10.19%
p-value: p=0.001
Serum adiponectin levels are significantly reduced in women with PCOS and correlate inversely with BMI and lipid profile, suggesting potential diagnostic and prognostic utility.
Lower adiponectin in young Indian women with PCOS may signal metabolic risk; leaves open biomarker utility pending prospective validation.
Polycystic Ovary Syndrome (PCOS) is a hormonal condition where women reproductive hormones are out of endocrinal balance. Women with PCOS frequently exhibit obesity, which causes irregularities in the levels of adipocytes like adiponectin. It is hypothesized that the altered adiponectin levels also play a role in the endocrine and metabolic abnormalities seen in PCOS women. We aimed to study the association of adiponectin levels with PCOS women. This case control study included 60 PCOS women under 30 age, and BMI matched healthy controls were recruited. For all the subjects Biochemical and serum adiponectin were determined. The serum adiponectin shows significantly decreased in PCOS women when compared to healthy controls (P <0.001**). This levels were inversely associated with BMI and total cholesterol, triglycerides in women with PCOS (P<0.001**). The significantly decreased levels of serum adiponectin can be useful for diagnostic and prognostic tool for PCOS in women and its application can be used for the success of specific emerging treatment modalities where the follow up shows improvement of levels of adiponectin.
No takes yet. Share an insight, caveat, or question.
Sudha Patil (2022) conducted a case-control in Polycystic Ovary Syndrome (n=90). Polycystic Ovary Syndrome vs. Healthy controls was evaluated on Serum adiponectin levels (μg/dL) (p=0.001). Women with polycystic ovary syndrome had significantly lower serum adiponectin levels compared to healthy controls (7.59 vs 10.19 μg/dL, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: